42510-8 |
IgD |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
IgD [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHEM |
|
42510-8 |
|
|
|
|
Both |
|
|
|
0 |
IgD Ur-mCnc |
|
|
|
N |
|
Chemistry; Immune globulin D; Immunoglobulin D; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.7 |
2.16 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
42511-6 |
IgD |
MCnc |
CSF |
Pt |
Qn |
|
|
ACTIVE |
IgD [Mass/volume] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHEM |
|
42511-6 |
|
|
|
|
Both |
|
|
|
0 |
IgD CSF-mCnc |
|
|
|
N |
|
Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Immune globulin D; Immunoglobulin D; Level; Mass concentration; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.7 |
2.16 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
42512-4 |
IgE |
ACnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
IgE [Units/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
arb U/mL |
|
|
|
|
|
|
CHEM |
|
42512-4 |
|
|
|
|
Both |
|
|
|
0 |
IgE Ur-aCnc |
|
|
|
N |
|
Arbitrary concentration; Chemistry; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.68 |
2.16 |
|
|
|
|
|
|
|
[IU]/mL |
|
|
|
0 |
42513-2 |
IgE |
ACnc |
CSF |
Pt |
Qn |
|
|
ACTIVE |
IgE [Units/volume] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
arb U/mL |
|
|
|
|
|
|
CHEM |
|
42513-2 |
|
|
|
|
Both |
|
|
|
0 |
IgE CSF-aCnc |
|
|
|
N |
|
Arbitrary concentration; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Immune globulin E; Immunoglobulin E; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.68 |
2.16 |
|
|
|
|
|
|
|
[IU]/mL |
|
|
|
0 |
42514-0 |
Inhibin Ag |
PrThr |
Tiss |
Pt |
Ord |
Immune stain |
|
ACTIVE |
Inhibin Ag [Presence] in Tissue by Immune stain |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH |
|
42514-0 |
|
Immune stain |
|
|
Both |
|
|
|
0 |
Inhibin Ag Tiss Ql ImStn |
|
|
|
N |
|
Antigen; Antigens; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified |
2.73 |
2.16 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
42515-7 |
Jamestown canyon virus RNA |
PrThr |
Urine |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Jamestown canyon virus RNA [Presence] in Urine by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
42515-7 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
JCV RNA Ur Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; JCV; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UR; Urn |
2.63 |
2.16 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
42516-5 |
Legionella sp Ab |
Titr |
CSF |
Pt |
SemiQn |
IF |
|
ACTIVE |
Legionella sp Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
42516-5 |
|
IF |
|
|
Both |
|
|
|
0 |
Legionella Ab Titr CSF IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Legion; Legionela; Microbiology; Neuro; Neurology; Point in time; Random; SmQn; species; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; spp; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.16 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
42517-3 |
Leishmania sp Ab |
PrThr |
CSF |
Pt |
Ord |
IF |
|
ACTIVE |
Leishmania sp Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
42517-3 |
|
IF |
|
|
Both |
|
|
|
0 |
Leishmania Ab CSF Ql IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Kala azar; Leishmaniasis; Leishmaniosis; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; species; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; spp; Time Resolved Fluorescence; TRF; Visceral leishmaniasis |
2.56 |
2.16 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
42518-1 |
Leptospira sp Ab |
Titr |
CSF |
Pt |
SemiQn |
Aggl |
|
ACTIVE |
Leptospira sp Ab [Titer] in Cerebral spinal fluid by Agglutination |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
42518-1 |
|
Aggl |
|
|
Both |
|
|
|
0 |
Leptospira Ab Titr CSF Aggl |
|
|
|
N |
|
ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Leptospirosis; Microbiology; Neuro; Neurology; Point in time; Random; SmQn; species; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; spp; Titer; Titered; Titre; Ttr |
2.75 |
2.16 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
42519-9 |
Measles virus Ab.IgG |
ACnc |
CSF |
Pt |
Ord |
|
|
DEPRECATED |
Deprecated Measles virus IgG Ab [Presence] in Cerebral spinal fluid |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
42519-9 |
|
|
|
|
Both |
|
|
|
0 |
Deprecated MeV IgG CSF Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MeV; Microbiology; Msls; Neuro; Neurology; Ordinal; Point in time; QL; Qual; Qualitative; Random; Rubeola; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.36 |
2.16 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
4252-3 |
Fenfluramine |
Mass |
Dose |
Pt |
Qn |
|
|
ACTIVE |
Fenfluramine [Mass] of Dose |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUGDOSE |
|
4252-3 |
|
|
|
|
Observation |
|
|
|
0 |
Fenfluramine Dose |
|
|
|
Y |
|
Dima-fen; Dose med or substance; DRUG DOSES; Fentrate; Fenured; Pesos; Point in time; Ponderal; Ponderax; Pondimin; Ponflurol; QNT; Quan; Quant; Quantitative; Random |
2.69 |
1 |
|
|
|
|
|
|
|
mg |
|
|
|
0 |
42520-7 |
Methylmalonate |
SCnc |
Urine |
24H |
Qn |
|
|
ACTIVE |
Methylmalonate [Moles/volume] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/L |
Low 1.6 High 29.7 |
|
|
|
|
|
CHEM |
|
42520-7 |
|
|
|
|
Both |
|
|
|
0 |
Methylmalonate 24h Ur-sCnc |
|
|
|
N |
|
1 day; 24 hours; 24HR; Chemistry; Level; Methylmalonic acid; Methylmalonic Acidemia; MMA; Propionic acidemia; QNT; Quan; Quant; Quantitative; Substance Concentration; UA; UR; Urn |
2.7 |
2.16 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
42521-5 |
Saccharopolyspora rectivirgula Ab |
PrThr |
CSF |
Pt |
Ord |
|
|
ACTIVE |
Saccharopolyspora rectivirgula Ab [Presence] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
42521-5 |
|
|
|
|
Both |
|
|
|
0 |
S rectivirgula Ab CSF Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; F retivirgula; Faenia rectivirgula; Farmers lung; ID; Infectious Disease; InfectiousDisease; M faeni; m212; m22; m50; Mcropolyspra; Microbiology; Micropolyspora faeni; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rm212; S rectivirgula; S retivirgula; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.56 |
2.16 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
42522-3 |
Mitochondria Ab |
Titr |
CSF |
Pt |
SemiQn |
|
|
ACTIVE |
Mitochondria Ab [Titer] in Cerebral spinal fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
SERO |
|
42522-3 |
|
|
|
|
Both |
|
|
|
0 |
Mitochondria Ab Titr CSF |
|
|
|
N |
|
ABS; Aby; AMA; Antby; Anti; Antibodies; Antibodies to Microtubule Associated Protein 2; Antibody; Antimitochondrial antibodies; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); M2; MA; Mito; Mitochon; Mitochond; Mitochondrial; Mitochondrial Ab; Neuro; Neurology; PBC; Point in time; Primary Biliary Cirrhosis; Random; S; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr |
2.75 |
2.16 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
42523-1 |
Molindone |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Molindone [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
30-70 ng/mL therapeutic range |
|
|
|
|
|
DRUG/TOX |
|
42523-1 |
|
|
|
|
Both |
|
|
|
0 |
Molindone Ur-mCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Moban; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.73 |
2.16 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
42524-9 |
Mucus |
PrThr |
Stool |
Pt |
Ord |
Microscopy.light |
|
ACTIVE |
Mucus [Presence] in Stool by Light microscopy |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
42524-9 |
|
Microscopy.light |
|
|
Both |
|
|
|
0 |
Mucous Threads Stl Ql Micro |
|
|
|
N |
|
Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; LM; Micro; Micros; Microscopic; Mucous; Mucous Threads; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal |
2.56 |
2.16 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
42525-6 |
Mycoplasma pneumoniae Ab.IgM |
Titr |
Plr fld |
Pt |
SemiQn |
IF |
|
ACTIVE |
Mycoplasma pneumoniae IgM Ab [Titer] in Pleural fluid by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
42525-6 |
|
IF |
|
|
Both |
|
|
|
0 |
M pneumo IgM Titr Plr IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); Enzootic pneumonia; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Lung; M pneumo; M pneumonia; M pneumoniae; Microbiology; Myco; Myco pneu; Mycoplas; Mycoplasm; Mycoplasmoides pneumoniae; Mycoplasmosis; Mycoplsm; Pleural; Pleural fluid; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; Pulmonary; Pulmonology; Random; Respiratory; SmQn; thoracentesis fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.16 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
42526-4 |
Mycoplasma pneumoniae Ab.IgG |
Titr |
Plr fld |
Pt |
SemiQn |
|
|
ACTIVE |
Mycoplasma pneumoniae IgG Ab [Titer] in Pleural fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
42526-4 |
|
|
|
|
Both |
|
|
|
0 |
M pneumo IgG Titr Plr |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); Enzootic pneumonia; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Lung; M pneumo; M pneumonia; M pneumoniae; Microbiology; Myco; Myco pneu; Mycoplas; Mycoplasm; Mycoplasmoides pneumoniae; Mycoplasmosis; Mycoplsm; Pleural; Pleural fluid; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; Pulmonary; Pulmonology; Random; Respiratory; SmQn; thoracentesis fluid; Titer; Titered; Titre; Ttr |
2.75 |
2.16 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
42527-2 |
Parietal cell Ab |
Titr |
CSF |
Pt |
SemiQn |
|
|
ACTIVE |
Parietal cell Ab [Titer] in Cerebral spinal fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
SERO |
|
42527-2 |
|
|
|
|
Both |
|
|
|
0 |
PCA Ab Titr CSF |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); Gastro; Gastroenterology; GI; Neuro; Neurology; PCA; Point in time; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr |
2.75 |
2.16 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
42528-0 |
Phenothiazines |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Phenothiazines [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
42528-0 |
|
|
|
|
Both |
|
|
|
0 |
Phenothiaz SerPl-mCnc |
|
|
|
N |
|
Dibenzothiazine; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Phenothiaz; Phenothiazine; Phenothiazn; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.7 |
2.16 |
|
|
|
|
|
|
|
ng/mL |
|
|
Changed component name from "Phenothiazine" (singular) to "Phenothiazines" (pleural) to better reflect its long term intended meaning and current conventions. . Phenothiazine is a distinct chemical but has never been used in human medicine. (It was used for parasitic diseases in animals decades ago but not now). The word phenothiazine has always been used to mean the class of drugs that are derived from phenothiazine and laboratories that use phenothiazine and phenothiazines to mean the measure of any drug of phenothiazine class contained in the specimen. |
0 |
42529-8 |
Pigeon serum Ab |
PrThr |
CSF |
Pt |
Ord |
|
|
ACTIVE |
Pigeon serum Ab [Presence] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ALLERGY |
|
42529-8 |
|
|
|
|
Both |
|
|
|
0 |
Pigeon Serum Ab CSF Ql |
|
|
|
N |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; e23; e93; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Ser; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SR |
2.56 |
2.16 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to Threshold to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
4253-1 |
Fenoprofen |
Mass |
Dose |
Pt |
Qn |
|
|
ACTIVE |
Fenoprofen [Mass] of Dose |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUGDOSE |
|
4253-1 |
|
|
|
|
Observation |
|
|
|
0 |
Fenoprofen Dose |
|
|
|
Y |
|
Dose med or substance; DRUG DOSES; Nalfon; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.69 |
1 |
|
|
|
|
|
|
|
mg |
|
|
|
0 |
42530-6 |
Smooth muscle Ab |
Titr |
CSF |
Pt |
SemiQn |
|
|
ACTIVE |
Smooth muscle Ab [Titer] in Cerebral spinal fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
SERO |
|
42530-6 |
|
|
|
|
Both |
|
|
|
0 |
Smooth muscle Ab Titr CSF |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; ASMA; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); Musc; Muscl; Neuro; Neurology; Point in time; Random; Serology; SM; SMA; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr |
2.75 |
2.16 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
42531-4 |
Spermatozoa.motile |
NCnc |
Semen |
Pt |
Qn |
|
|
ACTIVE |
Spermatozoa Motile [#/volume] in Semen |
|
MIN |
DefinitionDescription |
|
|
10*6/mL |
Mill |
|
|
|
|
|
FERT |
|
42531-4 |
|
|
|
|
Both |
|
|
|
0 |
Sperm Motile # Smn |
|
|
|
N |
|
#; ABS; absolute; absolutes; Cnt; Count; Count/volume; CT; Ejaculate; FERTILITY TESTING; Genitourinary; GU; Mot; Motile Sperm Concentration; MSC; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Sem; Seminal fluid; Smn; SMPLS; Sperm; Sperm Motile; URO; Urology |
2.73 |
2.16 |
|
|
|
|
|
|
|
10*6/mL |
|
|
|
0 |
42532-2 |
Thermoactinomyces candidus Ab |
PrThr |
CSF |
Pt |
Ord |
|
|
ACTIVE |
Thermoactinomyces candidus Ab [Presence] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
42532-2 |
|
|
|
|
Both |
|
|
|
0 |
T candidus Ab CSF Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Farmers lung; ID; Infectious Disease; InfectiousDisease; m58; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; T candidus; Thermoactnom |
2.56 |
2.16 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |